| Variable |
Group I: Placebo-Control Group (n=37) |
Group II: Ondansetron Study Group (n=39) |
Overall (n=76) |
| Oral Hydrocodone/Acetaminophen 5/500 Received, n (%) |
37 (100) |
37 (95) |
74 (97) |
| Oral oxycodone/acetaminophen 5/325 received, n (%) |
3 (8) |
3 (8) |
6 (8) |
| IV hydromorphone received, n (%) |
27 (73) |
27 (69) |
54 (71) |
| NRS1 pain score 3-10/10, n (%) |
28 (76) |
27 (69) |
55 (72) |
| Metoclopramide received, n (%) |
2 (5) |
6 (15) |
8 (11) |
| Additional anti-emetic received, n (%) |
1 (3) |
2 (5) |
3 (4) |
